Nov. 27 at 12:32 PM
$LGCL previous CFO will be succeeded by Wallace Wang Leong Lee, whose extensive experience includes leadership roles at various companies such as BON Natural Life Limited and China SXT Pharmaceuticals, Inc. This transition is expected to bring new strategic insights to the company’s financial management, potentially impacting its market operations positively. We can hope that the new CFO highlights company and company’s strategic plans more effectively to update all stakeholders.